Gut microbiota and hypertension: association, mechanisms and treatment

References

• Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–15. doi:10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Wu Y, Jin A, Xie G, Wang L, Liu K, Jia G, Liang X, Xu J. The 20 most important and most preventable health problems of China: a DelphI consultation of Chinese Experts. Am J Public Health. 2018;108(12):1592–98. doi:10.2105/ajph.2018.304684.
   PubMed Web of Science ®Google Scholar
• The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular health and diseases in China 2021: an updated summary. Chin Circ J. 2022;37:553–78. doi:10.3969/j.issn.1000-3614.2022.06.001.
   Google Scholar
• Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, et al. Status of Hypertension in China: results from the China Hypertension Survey, 2012-2015. Circulation. 2018;137(22):2344–56. doi:10.1161/CIRCULATIONAHA.117.032380.
   PubMed Web of Science ®Google Scholar
• Sekar D, Shilpa BR, Das AJ. Relevance of microRNA 21 in different Types of Hypertension. Curr Hypertens Rep. 2017;19(7):57. doi:10.1007/s11906-017-0752-z.
   PubMed Web of Science ®Google Scholar
• Pugh D, Dhaun N. Hypertension and Vascular inflammation another piece of the Genetic puzzle. Hypertension. 2021;77(1):190–92. doi:10.1161/Hypertensionaha.120.16420.
   PubMed Web of Science ®Google Scholar
• McMaster WG, Kirabo A, Madhur MS, Harrison DG. Inflammation, immunity, and Hypertensive end-organ damage. Circ Res. 2015;116(6):1022–33. doi:10.1161/Circresaha.116.303697.
   PubMed Web of Science ®Google Scholar
• Duan Y, Wu X, Yang Y, Gu L, Liu L, Yang Y, Zhou J, Wu C, Jin F. Marked shifts in gut microbial structure and neurotransmitter metabolism in fresh inmates revealed a close link between gut microbiota and mental health: a case-controlled study. Int J Clin Health Psychol. 2022;22(3):100323. doi:10.1016/j.ijchp.2022.100323.
   PubMed Web of Science ®Google Scholar
• Dong C, Yang Y, Wang Y, Hu X, Wang Q, Gao F, Sun S, Liu Q, Li L, Liu J, et al. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease. J Adv Res. 2022. doi:10.1016/j.jare.2022.06.008.
   Web of Science ®Google Scholar
• Miyauchi E, Shimokawa C, Steimle A, Desai MS, Ohno H. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat Rev Immunol. 2022;23(1):9–23. doi:10.1038/s41577-022-00727-y.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhao Y, Zhang Y, Yang Y, Su W, Yang Y, Sun L, Zhang F, Yu J, Wang Y, et al. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients. J Adv Res. 2022;37:197–208.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang Y, Zhang F, Yu J, Sun W, Wang R, Wu C. Traditional Chinese medicines differentially modulate the gut microbiota based on their nature (Yao-Xing). Phytomedicine. 2021;85:153496. doi:10.1016/j.phymed.2021.153496.
   PubMed Web of Science ®Google Scholar
• Yang YN, Wang QC, Xu W, Yu J, Zhang H, Wu C. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Biomed Pharmacother. 2022;155:113749. doi:10.1016/j.biopha.2022.113749.
   PubMed Web of Science ®Google Scholar
• McCulloch JA, Davar D, Rodrigues RR, Badger JH, Fang JR, Cole AM, Balaji AK, Vetizou M, Prescott SM, Fernandes MR, et al. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nat Med. 2022;28(3):545–56. doi:10.1038/s41591-022-01698-2.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. doi:10.1186/s40168-016-0222-x.
   PubMed Web of Science ®Google Scholar
• Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg EM, Richards EM, Pepine CJ, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci Lond. 2018;132(6):701–18. doi:10.1042/CS20180087.
   PubMed Web of Science ®Google Scholar
• Yan Q, Gu Y, Li X, Yang W, Jia L, Chen C, Han X, Huang Y, Zhao L, Li P, et al. Alterations of the Gut Microbiome in Hypertension. Front Cell Infect Microbiol. 2017;7:381.
   PubMed Web of Science ®Google Scholar
• Adnan S, Nelson JW, Ajami NJ, Venna VR, Petrosino JF, Bryan RM Jr., Durgan DJ. Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genomics. 2017;49(2):96–104. doi:10.1152/physiolgenomics.00081.2016.
   PubMed Web of Science ®Google Scholar
• Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, Haase S, Mahler A, Balogh A, Marko L, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 2017;551(7682):585–89. doi:10.1038/nature24628.
   PubMed Web of Science ®Google Scholar
• Dong JY, Szeto IMY, Makinen K, Gao QT, Wang JK, Qin LQ, Zhao YY. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Brit J Nutr. 2013;110(7):1188–94. doi:10.1017/S0007114513001712.
   PubMed Web of Science ®Google Scholar
• Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, Qi Y, Zubcevic J, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–40. doi:10.1161/hypertensionaha.115.05315.
   PubMed Web of Science ®Google Scholar
• Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, Haribabu B, Vijay-Kumar M, Pennathur S, Joe B. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics. 2015;47(6):187–97. doi:10.1152/physiolgenomics.00136.2014.
   PubMed Web of Science ®Google Scholar
• Bartolomaeus H, Balogh A, Yakoub M, Homann S, Marko L, Hoges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG, et al. Short-Chain fatty acid propionate protects from Hypertensive Cardiovascular damage. Circulation. 2019;139(11):1407–21. doi:10.1161/CIRCULATIONAHA.118.036652.
   PubMed Web of Science ®Google Scholar
• Sun S, Lulla A, Sioda M, Winglee K, Wu MC, Jacobs DR Jr., Shikany JM, Lloyd-Jones DM, Launer LJ, Fodor AA, et al. Gut microbiota composition and blood pressure. Hypertension. 2019;73(5):998–1006. doi:10.1161/HYPERTENSIONAHA.118.12109.
   PubMed Web of Science ®Google Scholar
• Dinakis E, Nakai M, Gill P, Ribeiro R, Yiallourou S, Sata Y, Muir J, Carrington M, Head GA, Kaye DM, et al. Association between the gut microbiome and their metabolites with human blood pressure variability. Hypertension. 2022;79(8):1690–701. doi:10.1161/Hypertensionaha.122.19350.
   PubMed Web of Science ®Google Scholar
• Chen WY, Chen YP, Feng T, Hu XW, Zhou FY, Lu XQ, Zhang QX, Zhang XL, Chen P, Xiu JC. Analysis of gut microbiota diversity in people with different cardiovascular risk stratified of hypertension. J Pract Med. 2019;35:1415–20. doi:10.3969/j.issn.1006⁃5725.2019.09.001.
   Google Scholar
• Liu J, An N, Ma C, Li X, Zhang J, Zhu W, Zhang Y, Li J. Correlation analysis of intestinal flora with hypertension. Exp Ther Med. 2018;16:2325–30. doi:10.3892/etm.2018.6500.
   PubMed Web of Science ®Google Scholar
• Palmu J, Salosensaari A, Havulinna AS, Cheng S, Inouye M, Jain M, Salido RA, Sanders K, Brennan C, Humphrey GC, et al. Association between the gut microbiota and blood pressure in a population Cohort of 6953 individuals. J Am Heart Assoc. 2020;9(15):e016641. doi:10.1161/jaha.120.016641.
   PubMed Web of Science ®Google Scholar
• Wu Q, Xu ZY, Liu LP, Zhang WY, Song SY. Role of gut microbiota in stress-induced hypertension in rats. Biotechnol Bulletin. 2020;36:83–90. doi:10.13560/j.cnki.biotech.bull.1985.2019-1215.
   Google Scholar
• Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, et al. High-fiber diet and Acetate supplementation change the gut microbiota and prevent the development of Hypertension and heart failure in Hypertensive mice. Circulation. 2017;135(10):964–77. doi:10.1161/CIRCULATIONAHA.116.024545.
   PubMed Web of Science ®Google Scholar
• Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, Hollister EB, Bryan RM Jr. Role of the gut microbiome in obstructive sleep Apnea–Induced Hypertension. Hypertension. 2016;67(2):469–74. doi:10.1161/HYPERTENSIONAHA.115.06672.
   PubMed Web of Science ®Google Scholar
• Druml W. Intestinal cross-talk: the gut as motor of multiple organ failure. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2018;113(6):470–77. doi:10.1007/s00063-018-0475-1.
   PubMed Web of Science ®Google Scholar
• Santisteban MM, Qi Y, Zubcevic J, Kim S, Yang T, Shenoy V, Cole-Jeffrey CT, Lobaton GO, Stewart DC, Rubiano A, et al. Hypertension-linked Pathophysiological alterations in the Gut. Circ Res. 2017;120(2):312–23. doi:10.1161/CIRCRESAHA.116.309006.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, Li J, Liu X, Liu J, Guo Z, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018;6(1):66. doi:10.1186/s40168-018-0441-4.
   PubMedGoogle Scholar
• Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, et al. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial translocation account for CKD–Related systemic inflammation. J Am Soc Nephrol. 2017;28(1):76–83. doi:10.1681/ASN.2015111285.
   PubMed Web of Science ®Google Scholar
• Lin D. Assocation between hypertension and impairment of intestinal barrier function. Guangzhou (CN): Guangdong Pharmaceutical University. 2019.
   Google Scholar
• Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Troseid M. Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med. 2013;14(6):354–61. doi:10.1111/hiv.12015.
   PubMed Web of Science ®Google Scholar
• Jaworska K, Huc T, Samborowska E, Dobrowolski L, Bielinska K, Gawlak M, Ufnal M, Chamaillard M. Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite. Plos One. 2017;12(12):e0189310. doi:10.1371/journal.pone.0189310.
   PubMed Web of Science ®Google Scholar
• Yang ZH, Liu YX, Wang L, Lin SS, Dai XD, Yan HF, Ge Z, Ren QA, Wang H, Zhu F, et al. Traditional Chinese medicine against COVID-19: role of the gut microbiota. Biomed Pharmacother. 2022;149:112787. 10.1016/j.biopha.2022.112787
   PubMed Web of Science ®Google Scholar
• Karbach SH, Schonfelder T, Brandao I, Wilms E, Hormann N, Jackel S, Schuler R, Finger S, Knorr M, Lagrange J, et al. Gut microbiota promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction. J Am Heart Assoc. 2016;5(9). doi:10.1161/JAHA.116.003698.
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitacion N, Sanchez M, Romero M, Olivares M, Jimenez R, Duarte J. The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative stress in rats with Hypertension induced by Chronic Nitric Oxide Blockade. Mol Nutr Food Res. 2018;62(19):e1800298. doi:10.1002/mnfr.201800298.
   PubMed Web of Science ®Google Scholar
• Yan PL, Luo YJ, Liu HF, Chen Y, Ge MH. Changes of gut microbiota and its correlation with serum inflammatory indexes in elderly patients with hypertensio. Chin J Gerontology. 2020;40:3871–74. doi:10.3969/j.issn.1005-9202.2020.18.021.
   Google Scholar
• Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal barrier in human health and disease. Int J Environ Res Public Health. 2021;18(23):12836. doi:10.3390/ijerph182312836.
   PubMed Web of Science ®Google Scholar
• Qiao J, Chen R, Wang M, Bai R, Cui X, Liu Y, Wu C, Chen C. Perturbation of gut microbiota plays an important role in micro/nanoplastics-induced gut barrier dysfunction. Nanoscale. 2021;13(19):8806–16. doi:10.1039/d1nr00038a.
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu Y, Wang L, Lin S, Dai X, Yan H, Ge Z, Ren Q, Wang H, Zhu F, et al. Traditional Chinese medicine against COVID-19: role of the gut microbiota. Biomed Pharmacother. 2022;149:112787.
   PubMed Web of Science ®Google Scholar
• Galla S, Chakraborty S, Mell B, Vijay-Kumar M, Joe B. Microbiotal-Host Interactions and Hypertension. Physiology. 2017;32(3):224–33. doi:10.1152/physiol.00003.2017.
   PubMed Web of Science ®Google Scholar
• Mushtaq N, Hussain S, Zhang S, Yuan L, Li H, Ullah S, Wang Y, Xu J. Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension. Int J Mol Med. 2019;44:513–22. doi:10.3892/ijmm.2019.4235.
   PubMed Web of Science ®Google Scholar
• Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy. 2020;16(1):38–51. doi:10.1080/15548627.2019.1635384.
   PubMed Web of Science ®Google Scholar
• Sircana A, De Michieli F, Parente R, Framarin L, Leone N, Berrutti M, Paschetta E, Bongiovanni D, Musso G. Gut microbiota, hypertension and chronic kidney disease: recent advances. Pharmacol res. 2019;144:390–408. doi:10.1016/j.phrs.2018.01.013.
   PubMed Web of Science ®Google Scholar
• Ferguson JF, Aden LA, Barbaro NR, Van Beusecum JP, Xiao L, Simmons AJ, Warden C, Pasic L, Himmel LE, Washington MK, et al. High dietary salt–induced DC activation underlies microbial dysbiosis-associated hypertension. JCI Insight. 2019;4(13):5. doi:10.1172/jci.insight.126241.
   Web of Science ®Google Scholar
• Zubcevic J, Richards EM, Yang T, Kim S, Sumners C, Pepine CJ, Raizada MK. Impaired autonomic nervous system-microbiome circuit in Hypertension. Circ Res. 2019;125(1):104–16. doi:10.1161/CIRCRESAHA.119.313965.
   PubMed Web of Science ®Google Scholar
• Yan X, Jin J, Su X, Yin X, Gao J, Wang X, Zhang S, Bu P, Wang M, Zhang Y, et al. Intestinal Flora modulates blood pressure by regulating the Synthesis of intestinal-derived Corticosterone in high salt-induced Hypertension. Circ Res. 2020;126(7):839–53. doi:10.1161/CIRCRESAHA.119.316394.
   PubMed Web of Science ®Google Scholar
• Huart J, Leenders J, Taminiau B, Descy J, Saint-Remy A, Daube G, Krzesinski J-M, Melin P, de Tullio P, Jouret F. Gut microbiota and fecal levels of short-Chain fatty acids differ upon 24-hour blood pressure levels in men. Hypertension. 2019;74(4):1005–13. doi:10.1161/hypertensionaha.118.12588.
   PubMed Web of Science ®Google Scholar
• Chen L, He FJ, Dong Y, Huang Y, Wang C, Harshfield GA, Zhu H. ModesT sodium reduction increases circulating short-Chain Fatty Acids in Untreated Hypertensives: a Randomized, Double-Blind, Placebo-Controlled Trial. Hypertension. 2020;76(1):73–79. doi:10.1161/HYPERTENSIONAHA.120.14800.
   PubMed Web of Science ®Google Scholar
• Mortensen FV, Nielsen H, Mulvany MJ, Hessov I. Short chain fatty acids dilate isolated human colonic resistance arteries. Gut. 1990;31(12):1391–94. doi:10.1136/gut.31.12.1391.
   PubMed Web of Science ®Google Scholar
• Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110(11):4410–15. doi:10.1073/pnas.1215927110.
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitacion N, Sanchez M, Gomez-Guzman M, Romero M, Yang T, Izquierdo-Garcia JL, Jimenez R, Ruiz-Cabello J, et al. Probiotics Prevent Dysbiosis and the rise in blood pressure in genetic Hypertension: role of Short-Chain Fatty Acids. Mol Nutr Food Res. 2020;64(6):e1900616. doi:10.1002/mnfr.201900616.
   PubMed Web of Science ®Google Scholar
• Tan JK, McKenzie C, Marino E, Macia L, Mackay CR. Metabolite-sensing G protein–Coupled Receptors—Facilitators of diet-related immune regulation. Annu Rev Immunol. 2017;35(1):371–402. doi:10.1146/annurev-immunol-051116-052235.
   PubMedGoogle Scholar
• Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278(28):25481–89. doi:10.1074/jbc.M301403200.
   PubMed Web of Science ®Google Scholar
• Felizardo RJF, de Almeida DC, Pereira RL, Watanabe IKM, Doimo NTS, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. Faseb J. 2019;33(11):11894–908. doi:10.1096/fj.201901080R.
   PubMed Web of Science ®Google Scholar
• Kaye DM, Shihata WA, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, et al. Deficiency of Prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors Leads to Cardiovascular disease. Circulation. 2020;141(17):1393–403. doi:10.1161/circulationaha.119.043081.
   PubMed Web of Science ®Google Scholar
• Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes. 2014;5(2):202–07. doi:10.4161/gmic.27492.
   PubMed Web of Science ®Google Scholar
• Nohr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, Schwartz TW, Moller M. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience. 2015;290:126–37. doi:10.1016/j.neuroscience.2015.01.040.
   PubMed Web of Science ®Google Scholar
• Sun M, Wu W, Chen L, Yang W, Huang X, Ma C, Chen F, Xiao Y, Zhao Y, Ma C, et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9(1):3555. doi:10.1038/s41467-018-05901-2.
   PubMed Web of Science ®Google Scholar
• Salazar Garcia MD, Mobley Y, Henson J, Davies M, Skariah A, Dambaeva S, Gilman-Sachs A, Beaman K, Lampley C, Kwak-Kim J. Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia. J Reprod Immunol. 2018;125:25–31. doi:10.1016/j.jri.2017.10.048.
   PubMed Web of Science ®Google Scholar
• Chen X, Li P, Liu M, Zheng H, He Y, Chen M-X, Tang W, Yue X, Huang Y, Zhuang L, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut. 2020;69(3):513–22. doi:10.1136/gutjnl-2019-319101.
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–55. doi:10.1038/nature12726.
   PubMed Web of Science ®Google Scholar
• Liu YJ, Tang B, Wang FC, Tang L, Lei YY, Luo Y, Huang SJ, Yang M, Wu LY, Wang W, et al. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner. Theranostics. 2020;10(12):5225–41. doi:10.7150/thno.43716.
   PubMed Web of Science ®Google Scholar
• Romano KA, Vivas EI, Amador-Noguez D, Rey FE, Blaser MJ. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6(2):e02481. doi:10.1128/mBio.02481-14.
   PubMed Web of Science ®Google Scholar
• Liu Y, Dai M. Trimethylamine N-Oxide generated by the gut microbiota is associated with Vascular inflammation: new insights into Atherosclerosis. Mediators Inflamm. 2020;2020:4634172. doi:10.1155/2020/4634172.
   PubMed Web of Science ®Google Scholar
• Duttaroy AK. Role of gut microbiota and their metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: a review. Nutrients. 2021;13(1):144. doi:10.3390/nu13010144.
   PubMed Web of Science ®Google Scholar
• Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G, Xi X, Zhou X, Fan H. The gut microbial metabolite Trimethylamine N-Oxide and Hypertension risk: a systematic review and dose–response meta-analysis. Adv Nutrition. 2020;11(1):66–76. doi:10.1093/advances/nmz064.
   PubMed Web of Science ®Google Scholar
• Jiang S, Shui Y, Cui Y, Tang C, Wang X, Qiu X, Hu W, Fei L, Li Y, Zhang S, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension. Redox Biol. 2021;46:102115.
   PubMed Web of Science ®Google Scholar
• Liu M, Han Q, Yang J. Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats. Clin Exp Hypertens. 2019;41(4):312–22. doi:10.1080/10641963.2018.1481420.
   PubMed Web of Science ®Google Scholar
• Chen H, Li J, Li N, Liu H, Tang J. Increased circulating trimethylamine N-oxide plays a contributory role in the development of endothelial dysfunction and hypertension in the RUPP rat model of preeclampsia. Hypertens Pregnancy. 2019;38(2):96–104. doi:10.1080/10641955.2019.1584630.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu C. Targeting gut microbial bile salt hydrolase (BSH) by diet supplements: new insights into dietary modulation of human health. Food Funct. 2022;13(14):7409–22. doi:10.1039/d2fo01252a.
   PubMed Web of Science ®Google Scholar
• Brown JM, Hazen SL. Microbial modulation of cardiovascular disease. Nat Rev Microbiol. 2018;16(3):171–81. doi:10.1038/nrmicro.2017.149.
   PubMed Web of Science ®Google Scholar
• Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert T-L, Riedl F, Mitteregger D, et al. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. J Hepatol. 2017;66(4):724–33. doi:10.1016/j.jhep.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Kida T, Omori K, Hori M, Ozaki H, Murata T. Stimulation of G protein–coupled bile acid receptor enhances Vascular Endothelial Barrier function via activation of protein Kinase a and Rac1. J Pharmacol Exp Ther. 2014;348(1):125–30. doi:10.1124/jpet.113.209288.
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Zampella A, Cirino G, Bucci M, Distrutti E. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators. Am J Physiol Heart Circ Physiol. 2017;312(1):H21–32. doi:10.1152/ajpheart.00577.2016.
   PubMed Web of Science ®Google Scholar
• Li S, Li C, Wang W. Bile acid signaling in renal water regulation. Am J Physiol Renal Physiol. 2019;317(1):F73–76. doi:10.1152/ajprenal.00563.2018.
   PubMed Web of Science ®Google Scholar
• Herman-Edelstein M, Weinstein T, Levi M. Bile acid receptors and the kidney. Curr Opin Nephrol Hypertens. 2018;27(1):56–62. doi:10.1097/MNH.0000000000000374.
   PubMed Web of Science ®Google Scholar
• Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. GuT microbiota in hypertension and Atherosclerosis: a review. Nutrients. 2020;12(10):2982. doi:10.3390/nu12102982.
   PubMed Web of Science ®Google Scholar
• D’agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, Praga M. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–71. doi:10.1038/nrneph.2016.75.
   PubMed Web of Science ®Google Scholar
• Cheng L, Huang C, Chen Z. Tauroursodeoxycholic acid Ameliorates Lipopolysaccharide-induced depression like behavior in mice via the inhibition of Neuroinflammation and oxido-Nitrosative stress. Pharmacology. 2019;103(1–2):93–100. doi:10.1159/000494139.
   PubMed Web of Science ®Google Scholar
• Kumar DP, Rajagopal S, Mahavadi S, Mirshahi F, Grider JR, Murthy KS, Sanyal AJ. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun. 2012;427(3):600–05. doi:10.1016/j.bbrc.2012.09.104.
   PubMed Web of Science ®Google Scholar
• Weber GJ, Foster J, Pushpakumar SB, Sen U. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation. Pharmacol res. 2018;134:157–65. doi:10.1016/j.phrs.2018.06.012.
   PubMed Web of Science ®Google Scholar
• Tomasova L, Dobrowolski L, Jurkowska H, Wrobel M, Huc T, Ondrias K, Ostaszewski R, Ufnal M. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric Oxide. 2016;60:50–58. doi:10.1016/j.niox.2016.09.007.
   PubMed Web of Science ®Google Scholar
• Huc T, Jurkowska H, Wrobel M, Jaworska K, Onyszkiewicz M, Ufnal M. Colonic hydrogen sulfide produces portal hypertension and systemic hypotension in rats. Exp Biol Med (Maywood). 2018;243(1):96–106. doi:10.1177/1535370217741869.
   PubMed Web of Science ®Google Scholar
• Weber GJ, Pushpakumar S, Tyagi SC, Sen U. Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol res. 2016;113:300–12. doi:10.1016/j.phrs.2016.09.002.
   PubMed Web of Science ®Google Scholar
• Tomasova L, Konopelski P, Ufnal M. Gut bacteria and Hydrogen Sulfide: the new old players in circulatory system Homeostasis. Molecules. 2016;21(11):1558. doi:10.3390/molecules21111558.
   PubMed Web of Science ®Google Scholar
• Battson ML, Lee DM, Weir TL, Gentile CL. The gut microbiota as a novel regulator of cardiovascular function and disease. J Nutr Biochem. 2018;56:1–15. doi:10.1016/j.jnutbio.2017.12.010.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhong S, Yu J, Zhu J, Ji D, Hu G, Wu C, Li Y, Singh UP. The aqueous extract of Phellinus igniarius (SH) ameliorates dextran sodium sulfate-induced colitis in C57BL/6 mice. Plos One. 2018;13(10):e0205007. doi:10.1371/journal.pone.0205007.
   PubMed Web of Science ®Google Scholar
• Grylls A, Seidler K, Neil J. Link between microbiota and hypertension: focus on LPS/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics. Biomed Pharmacother. 2021;137:111334. 10.1016/j.biopha.2021.111334
   PubMed Web of Science ®Google Scholar
• Toral M, Robles-Vera I, de la Visitacion N, Romero M, Yang T, Sanchez M, Gomez-Guzman M, Jimenez R, Raizada MK, Duarte J. CriticaL role of the interaction gut microbiota - Sympathetic nervous system in the regulation of blood pressure. Front Physiol. 2019;10:231. doi:10.3389/fphys.2019.00231.
   PubMed Web of Science ®Google Scholar
• Kim TT, Parajuli N, Sung MM, Bairwa SC, Levasseur J, Soltys CM, Wishart DS, Madsen K, Schertzer JD, Dyck JRB. Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. Am J Physiol Endocrinol Metab. 2018;315(4):E511–19. doi:10.1152/ajpendo.00471.2017.
   PubMed Web of Science ®Google Scholar
• Khalesi S, Sun J, Buys N, Jayasinghe R. Effect oF probiotics on blood pressure a systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64(4):897±. doi:10.1161/Hypertensionaha.114.03469.
   PubMed Web of Science ®Google Scholar
• Aoyagi Y, Park S, Matsubara S, Honda Y, Amamoto R, Kushiro A, Miyazaki K, Shephard RJ. Habitual intake of fermented milk products containing Lactobacillus casei strain Shirota and a reduced risk of hypertension in older people. Benef Microbes. 2017;8(1):23–29. doi:10.3920/Bm2016.0135.
   PubMed Web of Science ®Google Scholar
• Upadrasta A, Madempudi RS. Probiotics and blood pressure: current insights. Integr Blood Press Control. 2016;9:33–42. doi:10.2147/IBPC.S73246.
   PubMedGoogle Scholar
• Robles-Vera I, Toral M, Romero M, Jimenez R, Sanchez M, Perez-Vizcaino F, Duarte J. Antihypertensive Effects of Probiotics. Curr Hypertens Rep. 2017;19(4):26. doi:10.1007/s11906-017-0723-4.
   PubMed Web of Science ®Google Scholar
• Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen ML. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol. 2001;52(4 Pt 2):745–54.
   PubMed Web of Science ®Google Scholar
• Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, Tochikubo O, Ueshima H. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens. 2004;17(8):701–06. doi:10.1016/j.amjhyper.2004.03.674.
   PubMed Web of Science ®Google Scholar
• Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M, Sansawa H. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 2003;57(3):490–95. doi:10.1038/sj.ejcn.1601555.
   PubMed Web of Science ®Google Scholar
• Galla S, Chakraborty S, Cheng X, Yeo JY, Mell B, Chiu N, Wenceslau CF, Vijay-Kumar M, Joe B, Exposure to Amoxicillin in early life is associated with changes in gut microbiota and reduction in blood pressure: findings from a study on Rat Dams and Offspring. J Am Heart Assoc. 2020;9(2):e014373. doi:10.1161/JAHA.119.014373
   PubMed Web of Science ®Google Scholar
• Yoo HH, Kim IS, Yoo DH, Kim DH. Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction. J Hypertens. 2016;34(1):156–62. doi:10.1097/HJH.0000000000000773.
   PubMed Web of Science ®Google Scholar
• Qi Y, Aranda JM, Rodriguez V, Raizada MK, Pepine CJ. Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension - a case report. Int J Cardiol. 2015;201:157–58. doi:10.1016/j.ijcard.2015.07.078.
   PubMed Web of Science ®Google Scholar
• Galla S, Chakraborty S, Cheng X, Yeo J, Mell B, Zhang H, Mathew AV, Vijay-Kumar M, Joe B. Disparate effects of antibiotics on hypertension. Physiol Genomics. 2018;50(10):837–45. doi:10.1152/physiolgenomics.00073.2018.
   PubMed Web of Science ®Google Scholar
• Wang XH, Yang YN, Liang Y, Lang R, Zeng Q, Yan L, Yu RH, Wu CM. Structural modulation of gut microbiota during alleviation of experimental passive Heymann nephritis in rats by a traditional Chinese herbal formula. Biomed Pharmacother. 2022;145:112475. doi:10.1016/j.biopha.2021.112475.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhang X, Yu J, Tan Y, Guo P, Wu C. The gut microbiota confers the lipid-lowering effect of bitter melon (Momordica charantia L.) in high-fat diet (HFD)-Induced hyperlipidemic mice. Biomed Pharmacother. 2020;131:110667. doi:10.1016/j.biopha.2020.110667.
   PubMed Web of Science ®Google Scholar
• Wu C, Tian Y, Yu J, Zhang R, Zhang X, Guo P. The pandanus tectorius fruit extract (PTF) modulates the gut microbiota and exerts anti-hyperlipidaemic effects. Phytomedicine. 2019;58:152863. doi:10.1016/j.phymed.2019.152863.
   PubMed Web of Science ®Google Scholar
• Clarke SF, Murphy EF, O’sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O’reilly M, Jeffery IB, Wood-Martin R, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913–20. doi:10.1136/gutjnl-2013-306541.
   PubMed Web of Science ®Google Scholar
• Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, O’sullivan O. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018;67:625–33. doi:10.1136/gutjnl-2016-313627.
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitacion N, Sanchez M, Gomez-Guzman M, Munoz R, Algieri F, Vezza T, Jimenez R, Galvez J, et al. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects. Brit J Pharmacol. 2020;177(9):2006–23. doi:10.1111/bph.14965.
   PubMed Web of Science ®Google Scholar
• Xu XH, Yu XY, Jin H, Yan CL, Zhang QJ. The influence of Benazepril and Amlodipine on blood pressure and intestinal microbiom in spontaneously hypertensive rats. Chin J Microecol. 2020;32:379–83. doi:10.13381/j.cnki.cjm.202004002.
   Google Scholar
• Yang YN, Deng YT, Zang CC, Zhang F, Huang ZB, Dong L, Lu WY, Zhang XP, Wu CM. The gut microbial Co-Abundance Gene Groups (CAGs) differentially respond to the flavor (Yao-Wei) of Chinese Materia Medica. Am J Chin Med. 2022;50(08):2223–44. doi:10.1142/S0192415X22500963.
   PubMedGoogle Scholar
• Ma XC, Xiong XJ, Mo Y, Yue GH, Cai T, Huang J. Study on changes of intestinal microflora in Spontaneously Hypertensive Rats based on 16S rDNA sequencing and intervention of traditional Chinese Medicine. Chin Arch Tradit Chin Med. 2020; 38: 71-74+265-266. DOI:10.13193/j.issn.1673-7717.2020.08.017.
   Google Scholar
• Yang Y, Cao S, Xu W, Zang C, Zhang F, Xie Y, Wu C. Dual modulation of gut bacteria and fungi manifests the gut-based anti-hyperlipidemic effect of Coptidis Rhizoma. Biomed Pharmacother. 2022;153:113542. doi:10.1016/j.biopha.2022.113542.
   PubMed Web of Science ®Google Scholar
• Wu J, Nakashima S, Nakamura S, Matsuda H. Effects of Sanoshashinto on left ventricular hypertrophy and gut microbiota in spontaneously hypertensive rats. J Nat Med. 2020;74(2):482–86. doi:10.1007/s11418-020-01387-9.
   PubMed Web of Science ®Google Scholar
• Han C, Jiang YH, Li W, Liu Y, Qi ZQ, Bai WZ. Study on the mechanism of Astragalus and Salvia miltiorrhiza on intestinal flora of spontaneously hypertensive rats based on 16S rDNA sequencing technology. China J Tradit Chin Med Pharm. 2019;34:2233–37. doi:10.1155/2019/5418796.
   Google Scholar
• Qi YZ, Jiang YH, Jiang LY, Shao LL, Liu CY, Wang YG, Tao YN, Yang CH. Effects of Eucommia ulmoides-Tribulus terrestris on intestinal microbiota in aged spontaneously rats. Chin J Hypertens. 2019;27:454–62. doi:10.16439/j.cnki.1673-7245.2019.05.017.
   Google Scholar
• Xiong MQ, Tang XT, Cui JG, Li LL, Tang XM, Wang PW, Chen Y, Zhang T. Effects and mechanisms of Qinggan Yishen Qufeng formula in the treatment against gut barrier Dysfunction in Hypertension. Modernization Tradit Chin Med Materia Medica World Sci Technol. 2019;21:1939–47. doi:10.11842/wst.20190129002.
   Google Scholar
• Yu X, Zhang X, Jin H, Wu Z, Yan C, Liu Z, Xu X, Liu S, Zhu F. Zhengganxifeng decoction affects gut microbiota and reduces blood pressure via Renin–Angiotensin system. Biol Pharm Bull. 2019;42(9):1482–90. doi:10.1248/bpb.b19-00057.
   PubMed Web of Science ®Google Scholar
• Shi Y, Hu J, Geng J, Hu T, Wang B, Yan W, Jiang Y, Li J, Liu S. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. Biomed Pharmacother. 2018;107:1556–63. doi:10.1016/j.biopha.2018.08.148.
   PubMed Web of Science ®Google Scholar
• Gautam A, Paudel YN, Abidin S, Bhandari U. Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: an evidence from in vitro and in vivo studies. Hum Exp Toxicol. 2019;38(3):356–70. doi:10.1177/0960327118817862.
   PubMed Web of Science ®Google Scholar
• Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang QY, Mi MT. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio. 2016;7(2):e02210–15. doi:10.1128/mBio.02210-15.
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu J, Li JF. Effects and mechanism of quercetin on blood pressure，intestinal flora and ventricular remodeling in spontaneously hypertensive rats. Nat Prod Res Dev. 2020;32:1449–55. doi:10.16333/j.1001-6880.2020.9.001.
   Google Scholar
• Han C, Jiang YH, Li W, Liu Y, Qi ZQ. Study on the Antihypertensive mechanism of Astragalus membranaceus and Salvia miltiorrhiza based on Intestinal Flora-Host Metabolism. Evid Based Complement Alternat Med. 2019;2019:5418796. doi:10.1155/2019/5418796.
   PubMed Web of Science ®Google Scholar